BUYSELL, P anti-aging
"UBS" <7685> BUYSELL NEUTRAL → BUY upgrade "Daiwa" <4934> P Anti-Age 3 unchanged * The ratings of the above companies are confirmed by us as of 10/04.
recurringly ranked in POIL HD etc., launching a new product in the 'Wrinkle Shot' series.
Pola Orbis Holdings Inc. <4927> ranked in (as of 1:32 PM). Marked increase. They have announced the release of the quasi-drug first beauty serum "Wrinkle Shot Medical Serum Duo" from the "Wrinkle Shot" series, known for its wrinkle-improving effect, on January 1, 2025. The domestic sales plan seems to be 2.7 billion yen. The development seems to be leading with high expectations. Top changes in trading volume [October 4, 1:32 PM (latest 5-day average volume comparison)] Code Company name Volume
October 4th [Today's investment strategy]
[Fisco Selected Stocks] [Material Stocks] Kewpie <2809> 3524 yen (10/3) Engages in the production of mayonnaise, dressing for retail sale, liquid eggs for business use, etc. The third quarter financial results were announced. Cumulative operating profit is 29.8 billion yen (2.2 times higher than the same period last year). Contributing factors include increased sales of egg products, mitigated impact of soaring main raw material prices, and growth overseas. Operating profit for the fiscal year ending November 2024 is expected to be 34 billion yen (72.6% increase from the previous period). The progress rate at the third quarter stage relative to the full year forecast is 87.6%.
U.S. residence loans, refinancing activity picking up again.
[Residence] Customers who purchased a residence when the mortgage interest rate exceeded 7% can save hundreds of dollars per month by refinancing at a rate close to 6% now. Additionally, it is reported that if interest rates continue to decline as economists predict, customers can repeatedly refinance and further save money. <1419> Tamahome <1429> Japan Aqua <1766> Tokei Corp <1873> Japan House <1878> Dai-Tokken <1911> Sumitomo
Tokyo Century, SoftBank G, etc.
Tokyo Century <8439> to invest 1 trillion yen in aircraft, procure 120 aircraft for leasing, actively investing in response to expanding passenger demand (Nikkan Kogyo front page) - ○ ToppanHD <7911> aiming to achieve cross-organizational integration, synergy among the top 3 companies, targeting a revenue contribution of 20 billion yen (Nikkan Kogyo front page) - ○ SoftBank Group <9984> Chairman and President Son predicts the realization of "super intelligence" within 10 years (Nikkan Kogyo page 3) - ○ UBE <4208> acquires the polyurethane business of German Lansa Access for 73.6 billion yen (Nikkan Kogyo page 3) - ○ Wealth
Keep an eye on Aoki Pharmaceuticals and Kewpie, while Mizuhikari and others are subdued.
In the U.S. stock market on the 3rd, the dow jones industrial average closed at 42,011.59, down 184.93 points, the nasdaq composite index closed down 6.64 points at 17,918.48, and the Chicago Nikkei 225 futures closed at 38,625 yen, up 25 yen from Osaka day session. The exchange rate was 1 dollar = 146.90-147.00 yen. In today's Tokyo market, Aoki, a drug company <3549>, announced a share buyback of up to 5.71% of the issued shares with a 10.2% increase in first-quarter operating profit, while first-half operating profit increased by 34.4%.